We observed that tumor purity was significantly enriched in IDH-mutant samples or MGMT-promoter-methylated samples (student’s t-test, P < 0.001, P = 0.024, respectively) (Additional file 2: Fig. S1), which were associated with favorable prognosis. This evidence concerns the gene MGMT and neoplasm.